Nvelop Therapeutics

Nvelop Therapeutics

Developing innovative genetic medicines using novel gene editing delivery technologies, with a focus on severe genetic diseases, and led by world-class scientific founders, and funded by leading life science venture capital firms.

HQ location
Cambridge, United States
Launch date
Employees
Enterprise value
$400—600m
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor investor investor investor

€0.0

round
*

N/A

Merger
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by Nvelop Therapeutics

Edit